Mechanisms of action of interferon and ribavirin in chronic hepatitis C: Summary of a workshop. - Wikidata - awgldk - TriplyDB

Mechanisms of action of interferon and ribavirin in chronic hepatitis C: Summary of a workshop.

Mechanisms of action of interferon and ribavirin in chronic hepatitis C: Summary of a workshop.

http://www.wikidata.org/entity/Q27490650

about

Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha Debio 025, a cyclophilin binding molecule, is highly efficient in clearing hepatitis C virus (HCV) replicon-containing cells when used alone or in combination with specifically targeted antiviral therapy for HCV (STAT-C) inhibitors Safety and Efficacy of Adding Ribavirin to Interferon or Peginterferon in Treatment of Hepatitis C Infection in Patients With Thalassemia: A Systematic Review on Randomized Controlled Trials Combinations of siRNAs against La Autoantigen with NS5B or hVAP-A Have Additive Effect on Inhibition of HCV Replication Direct Infection and Replication of Naturally Occurring Hepatitis C Virus Genotypes 1, 2, 3 and 4 in Normal Human Hepatocyte Cultures Comparative In Vitro Anti-Hepatitis C Virus Activities of a Selected Series of Polymerase, Protease, and Helicase Inhibitors Mutagenic Effects of Ribavirin on Hepatitis E Virus-Viral Extinction versus Selection of Fitness-Enhancing Mutations Sensitivity of a ribavirin resistant mutant of hepatitis C virus to other antiviral drugs In vivo anti-HIV activity of the heparin-activated serine protease inhibitor antithrombin III encapsulated in lymph-targeting immunoliposomes.Effects of an 11-nm DMSA-coated iron nanoparticle on the gene expression profile of two human cell lines, THP-1 and HepG2 Coinfection with HIV-1 and HCV--a one-two punch.Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial Avoiding therapeutic pitfalls: the rational use of specifically targeted agents against hepatitis C infection.Pretreatment serum interleukin-12 levels in predicting sustained virological response among hepatitis C patients following Pegylated Interferon-α2β plus Ribavirin treatment Environmental triggers of thyroiditis: hepatitis C and interferon-α.Interferon combination therapy for HIV/hepatitis C virus coinfection.The role of ribavirin in direct acting antiviral drug regimens for chronic hepatitis C.Selection of hepatitis C virus resistant to ribavirin.Ribavirin induced hemolysis: a novel mechanism of action against chronic hepatitis C virus infection Cleavage of mitochondrial antiviral signaling protein in the liver of patients with chronic hepatitis C correlates with a reduced activation of the endogenous interferon system.The discovery of sofosbuvir: a revolution for therapy of chronic hepatitis C.T-cell homeostasis in chronic HCV-infected patients treated with interferon and ribavirin or an interferon-free regimen.Effects of ribavirin monotherapy on the viral population in patients with chronic hepatitis C genotype 1: direct sequencing and pyrosequencing of the HCV regions.Undetectable hepatitis C virus RNA during syphilis infection in two HIV/HCV-co-infected patients.Inhibition of HCV by the serpin antithrombin III Association of hepatitis C virus NS5B variants with resistance to new antiviral drugs among untreated patients.Single and combined IL28B, ITPA and SLC28A3 host genetic markers modulating response to anti-hepatitis C therapy.Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular methods.A prediction model for the grade of liver fibrosis using magnetic resonance elastography.Immunosuppression as a Possible Risk Factor for Interferon Nonresponse in Ocular Surface Squamous Neoplasia.A fresh look at interferon-alpha signaling and treatment outcomes in chronic hepatitis C.Immobilization of Neutral Protease from Bacillus subtilis for Regioselective Hydrolysis of Acetylated Nucleosides: Application to Capecitabine Synthesis.Impact of direct-acting antiviral agents on the development of hepatocellular carcinoma: evidence and pathophysiological issues

P2860

Q21245110-E7D029BE-71D7-4ABD-92DF-58C40BF03D80 Q24645702-9ED23A09-27F5-4879-AC21-4EDD6C183C66 Q26745895-177A35FC-116A-49C4-859C-7E5C312DED46 Q27469011-A0B7080D-158D-4AF9-9852-03F101B4C36E Q27486394-D435A34A-F142-4B1C-9C2F-9374E4C01946 Q27486813-D05CB924-68A4-447D-970B-68C264C60CCF Q28072953-39706A25-FD3C-4412-AA57-3AD9DFC676E2 Q28536754-011DEF2B-6B4B-4B30-B6BF-765776DC5118 Q34469655-D835B790-4822-4E80-B433-A06FC23D3934 Q35005026-AB4E0115-58D6-438D-BAFE-096670F2EC1E Q35137038-1A5B377F-E162-41E8-AD14-901C90CF0EC9 Q37217280-AE17BFC2-4647-4048-A3B9-30295A95B597 Q37313166-41C902B4-1144-4EFC-BE81-1EDB8DC512C5 Q37647505-03772822-50F7-446E-8685-9EC72FCAEAC1 Q37836257-5E257627-68DC-4684-B8A6-2FCDB4268687 Q37931258-64DAFBDC-F69E-4ABB-A03A-FB164C0E8949 Q37972769-231F1E80-4F09-4C69-9132-8239FEC24D6D Q38269623-82095186-FF8E-41C5-A01D-351498AA5932 Q38282854-1C01D760-84B3-4E9A-A0F0-927ED36EEF1A Q39756691-EF33C4D4-95BD-440C-9F3A-D391F6517238 Q40326326-C21AF7DF-6D8F-4212-92C9-6B6A2E5F6927 Q41049230-D8CD51A3-9E0B-4F14-A58B-BC88EDEEF093 Q42202008-1C0A47B9-82D0-4A97-BBF9-604EAC1E1B1A Q42210283-CAAF6142-C421-47AA-B91E-6F1F4A7CAFD8 Q42406960-2FF1F5DB-6D6E-45DA-AD51-68AAFF4A771A Q43046674-3E42EA5F-22D9-4DFC-BCF6-481759C4BE2D Q43048075-65249600-57B7-4FDA-94B4-1D5C68FC5B68 Q47132671-96BA7FAB-4A78-4488-9B06-6CF24C271CCC Q47139016-0F4BBBA8-9214-42C9-8661-CD5EDCA0ED64 Q47983897-40035E00-9E7D-46E9-8C22-C8CBD8CF493E Q50567340-C8BE7066-2306-4C21-B5C6-F1D4CB435002 Q51297775-23553BDF-1155-47B4-B92E-88E368419173 Q58541835-076F8EEB-2C9C-4255-9CA5-56638B672FB8

P2860

Mechanisms of action of interferon and ribavirin in chronic hepatitis C: Summary of a workshop.

http://www.wikidata.org/entity/Q27490650

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Mechanisms of action of interf ...... titis C: Summary of a workshop

@nl

Mechanisms of action of interf ...... itis C: Summary of a workshop.

@ast

Mechanisms of action of interf ...... itis C: Summary of a workshop.

@en

type

label

Mechanisms of action of interf ...... titis C: Summary of a workshop

@nl

Mechanisms of action of interf ...... itis C: Summary of a workshop.

@ast

Mechanisms of action of interf ...... itis C: Summary of a workshop.

@en

prefLabel

Mechanisms of action of interf ...... titis C: Summary of a workshop

@nl

Mechanisms of action of interf ...... itis C: Summary of a workshop.

@ast

Mechanisms of action of interf ...... itis C: Summary of a workshop.

@en

P1433

Q27490650-017D4F63-52CA-4B9A-8363-8C2741502337

P1476

Q27490650-E9CAA8E9-A9E9-4912-8D39-81F90D743310

P2093

Q27490650-1BCF1E4D-E100-4B81-988F-8B2C76CB7F7D

Q27490650-35318DFA-A0BE-4B99-8944-5B4F72412151

Q27490650-92993FAD-3436-4C5F-9EFE-F7C2096F8460

Q27490650-B59C4C3C-1F45-46F5-96A5-FEF9C01886DC

Q27490650-E7F0621B-2E31-4368-A1AA-BDB254B24F1C

P2860

Q27490650-06E04D1A-D107-4EC7-B36C-3AFDEC76B0B8

Q27490650-0995CB98-A9C9-403C-997C-DD1223D0E8F9

Q27490650-0C301D65-AF5D-4FA8-B695-407C1B5AEA82

Q27490650-0D1154F6-F260-4AEB-B835-9112A53BE540

Q27490650-155F77D4-EE2D-4CF4-B234-68472B0CFEDB

Q27490650-15AF133E-721D-4248-9D6D-7FAD99F0336D

Q27490650-174324EC-73AC-48D1-918F-4806AAC98D43

Q27490650-186B5C0C-74B2-4424-944B-F98A2ADA7478

Q27490650-21233F31-37DE-4165-B404-14DB97167A9D

Q27490650-24C448D6-C19F-45E8-B030-4FB5CA42BA53

P304

Q27490650-8157C6F2-DB86-41D4-8524-B463903E1510

P31

Q27490650-BDDB5C8F-7CC8-4F56-81BB-67A7A4DB731B

P3181

Q27490650-58026AED-0B66-427A-8695-17AB8B61E4EA

P356

Q27490650-39CD8BCF-CC2A-48E7-B114-DAA78F959626

P407

Q27490650-9A7C7AB4-AC66-47E0-BE77-FB71A1A94DD2

P433

Q27490650-DA9201D7-6713-4C1A-A5D8-F30FD3CC9667

P478

Q27490650-F2EC5EB9-F8DA-4BD4-91A6-2ED3A9653281

P50

Q27490650-E6A288C3-35A5-4F1C-8C1F-C7EAEACB2426

P577

Q27490650-3F964DC0-8EBC-46AB-9A04-EDB833B26FD0

P5875

Q27490650-D612C997-1257-4B68-913A-4F2A9C2B8DFF

P698

Q27490650-63926AA7-352B-4EA3-B009-9A717BBD7DCC

P921

Q27490650-07141C3A-DE6C-49BE-80DC-FE1879E75B10

P932

Q27490650-D5D7A1ED-9ED7-45B0-9CF9-997178F4BDCB

P3181

P356

P1433

P1476

Mechanisms of action of interf ...... itis C: Summary of a workshop.

@en

P2093

Jay H Hoofnagle

http://www.w3.org/2001/XMLSchema#string

Raymond T Chung

http://www.w3.org/2001/XMLSchema#string

Stanley M Lemon

http://www.w3.org/2001/XMLSchema#string

Stephen J Polyak

http://www.w3.org/2001/XMLSchema#string

T Jake Liang

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein

Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation.

Hepatitis C virus expression suppresses interferon signaling by degrading STAT1

Hepatitis C virus core protein blocks interferon signaling by interaction with the STAT1 SH2 domain

Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors

Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus

Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection

A general method for nested RT-PCR amplification and sequencing the complete HCV genotype 1 open reading frame.

Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway

Regulation of PKR and IRF-1 during hepatitis C virus RNA replication.

P304

306-320

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

421144

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/HEP.22070

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5687233

http://www.w3.org/2001/XMLSchema#string

P698

18161743

http://www.w3.org/2001/XMLSchema#string

P921

P932

2799164

http://www.w3.org/2001/XMLSchema#string